Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Vitara RX
Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
Published by The GLP-1 Verdict
Pricing sources checked: CoreAge Rx: August 2026 · Vitara RX: Check date not recorded
vs
Verdict64/ 100
Grade C · #285Vitara RX
Genuinely flat pricing across every printed dose, with consultation and shipping included — undercut by thin corporate accountability.
Visit Vitara RXThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 64/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Vitara RX still earns its place — anyone who wants a price that does not rise as they titrate up.
The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results70
92
Real-world results70
97Price honesty90
97
Price honesty90
96Prescriber access60
96
Prescriber access60
88Formulary choice40
88
Formulary choice40
95Cancellation fairness60
95
Cancellation fairness60
93Member support50
93
Member support50
Price, coverage & features
| Metric | CoreAge Rx | Vitara RX |
|---|---|---|
| Verdict Score | 94/100 | 64/100 |
| Grade | A | C |
| Semaglutide | $99/mo | $99/mo |
| Tirzepatide | $149/mo | $149/mo |
| Coverage | All 50 states | 49 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Vitara RX
What we like
- Flat pricing is real and dose-itemised: $99/mo covers 0.25, 0.5, 1, 1.5, 2 and 2.5 mg semaglutide, $149/mo covers 2.5 through 15 mg tirzepatide
- The monthly figure includes 'online consultation, medication, and shipping' with no membership fee
- Names its compounding pharmacy partner, Manifest Pharmacy of Greer, South Carolina
- Publishes the FDA compounded-medication disclaimer and states plainly that Wegovy, Ozempic, Mounjaro and Zepbound come only from Novo Nordisk and Eli Lilly
- Coverage is an explicit 49-state list rather than a vague nationwide claim
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved finished drug products and have not been reviewed by FDA for safety or efficacy
- No corporate legal entity is disclosed anywhere — the trade name 'VitaraRx' appears with no LLC or Inc behind it
- All sales are final: 'Federal and State law do not allow medication returns', though future refills can be canceled from the account
- No named medical director; clinical decisions sit with independent providers routed through MD Integrations
- Compounded only, no oral GLP-1, and Alaska is not served
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Anyone who wants a price that does not rise as they titrate up.
Visit Vitara RX Read the full Vitara RX review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Vitara RX does the reverse.
More on CoreAge Rx
More on Vitara RX
Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.